0
0
3/10/26 at 10:12pm
Organization
Ars Technica
Author
Beth Mole
30 words
0
Comments
In the end, the FDA only approved the drug for a rare genetic condition with clearer data.
You are the first to view
https://arstechnica.com/health/2026/03/fda-contradicts-trump-admin-declines-to-approve-generic-drug-for-autism/
Create an account
or login to join the discussion